Acceleron Pharma
(XLRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,391 | -50,939 | -124,858 | -101,283 | -55,913 |
| Depreciation Amortization | 1,938 | 996 | 3,941 | 2,932 | 1,942 |
| Accounts receivable | -31,205 | 112 | -1,508 | 164 | 1,592 |
| Accounts payable and accrued liabilities | 10,334 | 1,634 | 1,876 | 1,435 | 3,129 |
| Other Working Capital | -37,330 | -4,646 | 3,990 | 3,563 | 1,055 |
| Other Operating Activity | 36,253 | 6,298 | 22,755 | 15,636 | 7,687 |
| Operating Cash Flow | $-89,401 | $-46,545 | $-93,804 | $-77,553 | $-40,508 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 168,385 | 88,361 | 327,134 | 228,258 | 104,201 |
| PPE Investments | -2,420 | -426 | -3,287 | -2,166 | -1,273 |
| Purchase Of Investment | -58,539 | -10,454 | -395,138 | -379,096 | -293,913 |
| Investing Cash Flow | $107,426 | $77,481 | $-71,291 | $-153,004 | $-190,985 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 248,130 | 248,130 | 248,130 |
| Other Financing Activity | 27,819 | 8,873 | 10,590 | 7,917 | 2,920 |
| Financing Cash Flow | $27,819 | $8,873 | $258,720 | $256,047 | $251,050 |
| Beginning Cash Position | 239,274 | 239,274 | 145,649 | 145,649 | 145,649 |
| End Cash Position | 285,118 | 279,083 | 239,274 | 171,139 | 165,206 |
| Net Cash Flow | $45,844 | $39,809 | $93,625 | $25,490 | $19,557 |
| Free Cash Flow | |||||
| Operating Cash Flow | -89,401 | -46,545 | -93,804 | -77,553 | -40,508 |
| Capital Expenditure | -2,420 | -426 | -3,287 | -2,166 | -1,273 |
| Free Cash Flow | -91,821 | -46,971 | -97,091 | -79,719 | -41,781 |